Patent ductus arteriosus (PDA) with a significant left-right shunt is associated with chronic lung disease (CLD), intraventricular haemorrhage (IVH) and necrotising enterocolitis (NEC). Surgical ...

Philadelphia, PA - Using a strategy that takes the classic "house-call" to new extremes, a traveling medical team made up of cardiothoracic surgeons, anesthesiologists, and nurses is bringing a ...

From the Laboratory of Surgical Research, Harvard Medical School, and the Department of Surgery, Children's Hospital, Boston. Select the format you want to export the citation of this publication.

“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...

Please provide your email address to receive an email when new articles are posted on . Compared with surgical ligation, transcatheter closure of the patent ductus arteriosus in infants and neonates ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.

None of these approaches has shown clear benefits in short- and long-range outcomes.

Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Merit Medical Systems, Inc. has announced the enrollment ...